Urinary Incontinence News and Research

RSS
Urinary incontinence (UI), or the unintentional loss of urine, is a problem for more than 13 million Americans—85 percent of them women. Although about half of the elderly have episodes of incontinence, bladder problems are not a natural consequence of aging, and they are not exclusively a problem of the elderly.

Incontinence has several causes. Women are most likely to develop incontinence either during pregnancy and childbirth, or after the hormonal changes of menopause, because of weakened pelvic muscles. Older men can become incontinent as the result of prostate surgery. Pelvic trauma, spinal cord damage, caffeine, or medications including cold or over-the-counter diet tablets also can cause episodes of incontinence.

But even though urinary incontinence can be improved in 8 out of 10 cases, fewer than half of those with bladder problems ever discuss the condition with their health care professional. The condition often goes untreated.
MediciNova announces $15 million senior secured term loan with Oxford Finance

MediciNova announces $15 million senior secured term loan with Oxford Finance

PTNS performed using Urgent PC Neuromodulation System to receive category 1 CPT reimbursement code

PTNS performed using Urgent PC Neuromodulation System to receive category 1 CPT reimbursement code

Pelvic Floor Institute launched to enhance physician knowledge on reconstruction procedures, techniques

Pelvic Floor Institute launched to enhance physician knowledge on reconstruction procedures, techniques

University of Nevada professor awarded NIH RO1 grant for study of control of motility in internal anal sphincter

University of Nevada professor awarded NIH RO1 grant for study of control of motility in internal anal sphincter

Contura submits PMA for Aquamid

Contura submits PMA for Aquamid

New study to compare Botox against oral medications for urge incontinence in women

New study to compare Botox against oral medications for urge incontinence in women

Clinical utility and pharmacological action of MN-166 in treatment of MS

Clinical utility and pharmacological action of MN-166 in treatment of MS

NAFC supports PMAA of Uromedica's ACT device for SUI, speaks to FDA

NAFC supports PMAA of Uromedica's ACT device for SUI, speaks to FDA

WOCN Society launches campaign to raise awareness about benefits of specialized care

WOCN Society launches campaign to raise awareness about benefits of specialized care

USPTO allows Pisgah Labs' patent application regarding imipramine pamoate

USPTO allows Pisgah Labs' patent application regarding imipramine pamoate

Beaumont Hospital opens women's urology center

Beaumont Hospital opens women's urology center

MediciNova reports net loss of $5.9 million for 2009 fourth quarter

MediciNova reports net loss of $5.9 million for 2009 fourth quarter

Uroplasty announces newly-issued patent for Urgent PC Neuromodulation System

Uroplasty announces newly-issued patent for Urgent PC Neuromodulation System

Positive preliminary results from MediciNova's Phase Ib clinical trial of MN-221 for COPD

Positive preliminary results from MediciNova's Phase Ib clinical trial of MN-221 for COPD

Adult female stress urinary incontinence: Uroplasty launches new endoscopic injection needle

Adult female stress urinary incontinence: Uroplasty launches new endoscopic injection needle

Type of specialist that men with prostate cancer see can influence form of therapy they ultimately receive

Type of specialist that men with prostate cancer see can influence form of therapy they ultimately receive

Likvor receives first order for Likvor CELDA system from Aalborg Hospital, North Denmark Region

Likvor receives first order for Likvor CELDA system from Aalborg Hospital, North Denmark Region

Urinary catheterization of men and women: NAFC releases new consumer educational resource

Urinary catheterization of men and women: NAFC releases new consumer educational resource

Macroplastique effective for stress urinary incontinence in women

Macroplastique effective for stress urinary incontinence in women

Antares Pharma completes enrollment in Phase 3 clinical trial of Anturol for OAB

Antares Pharma completes enrollment in Phase 3 clinical trial of Anturol for OAB